Disclosures for "Phase Ib Study Design Evaluating The Safety, Pharmacokinetics And Pharmacodynamics Of Selnoflast, A Novel NLRP3 Inflammasome Inhibitor In Early-Stage PD")
-
Dr. D'Urso has received personal compensation for serving as an employee of Hoffmann la Roche Ltd.
-
Alessandra Thomann has received personal compensation for serving as an employee of F.Hoffmann-La Roche Ltd.
-
Dr. Anzures-Cabrera has received personal compensation for serving as an employee of Roche Products Ltd. Dr. Anzures-Cabrera has stock in Roche.
-
Dr. Zinnhardt has nothing to disclose.
-
Mrs. Ricci has received personal compensation for serving as an employee of Roche. Mrs. Ricci has stock in Roche.
-
Dr. Bailey has received personal compensation for serving as an employee of Roche Products Ltd. Dr. Bailey has stock in Roche Products Ltd.
-
Dr. Smigorski has received personal compensation for serving as an employee of F. Hoffman-La Roche AG. Dr. Smigorski has received personal compensation for serving as an employee of Syneos Health Ltd..
-
Dr. Machado has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG.
-
Dr. Mracsko has nothing to disclose.
-
Dr. Pavese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. The institution of Dr. Pavese has received research support from Multiple System Atrophy Trust. The institution of Dr. Pavese has received research support from Parkinson's UK. The institution of Dr. Pavese has received research support from Independent Research Fund Denmark. The institution of Dr. Pavese has received research support from European Union. The institution of Dr. Pavese has received research support from MRC.
-
Dr. Marek has received personal compensation for serving as an employee of IND. Dr. Marek has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for invicro. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for takeda. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkahest. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Marek has received research support from Michael J Fox Foundation.
-
Kathrin Brockmann has received personal compensation in the range of $0-$499 for serving as a Consultant for Hoffmann-La Roche LTD. The institution of Kathrin Brockmann has received research support from Michael J Fox Foundation. The institution of Kathrin Brockmann has received research support from German Research Society. The institution of Kathrin Brockmann has received research support from Health Forum Baden Wuerttemberg. The institution of Kathrin Brockmann has received research support from Else Kröner Fresenius Stiftung.
-
Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia, Abbvie, Accorda, Adamas, Allergan, Amneal, Aptinyx, Denali, General Electric (GE), Kyowa, Neuroderm, Neurocrine, Sanofi, Sinopia, Sunovion, Roche, Takeda, Voyager, US World Meds, Parkinson's Foundation, and the Michael J. Fox Foundation for Parkinson's Research. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm and Sanofi. Dr. Simuni has received research support from NINDS, Parkinson's Foundation, MJFF, Biogen, Roche, Neuroderm, Sanofi, Sun Pharma, Abbvie, IMPAX and Prevail. .
-
Nicoletta Milani Muelhardt has stock in F. Hoffmann-La Roche Ltd. Nicoletta Milani Muelhardt has received personal compensation in the range of $100,000-$499,999 for serving as a full-time employee with F. Hoffmann-La Roche Ltd.
-
Prof. Pagano has received personal compensation for serving as an employee of F.Hoffmann-La Roche Ltd. Prof. Pagano has stock in F.Hoffmann La Roche Ltd.